Early trial of new multi-kinase inhibitor shows impressive activity in thyroid cancer
October 23, 2008 by admin · Leave a Comment
Preliminary trials of a new multi-kinase inhibitor have indicated it has impressive tumour shrinkage activity in patients with a difficult to treat type of thyroid cancer. The results have put the drug’s development on a fast track, prompting the accelerated initiation of a large phase III trial.
